• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A pilot training program for a motivational enhancement approach to hepatitis C virus treatment among individuals in Israeli methadone treatment centers.以色列美沙酮治疗中心个体丙型肝炎病毒治疗动机增强方法的试点培训计划。
Subst Use Misuse. 2012 Jan;47(1):56-66. doi: 10.3109/10826084.2011.628735.
2
Informal discussions in substance abuse treatment sessions.药物滥用治疗环节中的非正式讨论。
J Subst Abuse Treat. 2009 Jun;36(4):366-75. doi: 10.1016/j.jsat.2008.08.003. Epub 2008 Oct 5.
3
A comparison of HCV antibody testing in drug-free and methadone maintenance treatment programs in the United States.美国戒毒项目和美沙酮维持治疗项目中丙型肝炎病毒抗体检测的比较。
Drug Alcohol Depend. 2004 Mar 8;73(3):227-36. doi: 10.1016/j.drugalcdep.2003.08.009.
4
Assessment of methadone clinic staff attitudes toward hepatitis C evaluation and treatment.评估美沙酮诊所工作人员对丙型肝炎评估和治疗的态度。
J Subst Abuse Treat. 2013 Jan;44(1):115-9. doi: 10.1016/j.jsat.2012.01.010. Epub 2012 Mar 8.
5
Medical examinations at entry to treatment for drug abuse as an opportunity to initiate care for hepatitis C virus infection.
Clin Infect Dis. 2005 Apr 15;40 Suppl 5:S297-303. doi: 10.1086/427444.
6
Assessment of the relationship between a written measure of empathy and an independently rated interview of Motivational Interviewing.评估书面同理心测量与独立评定的动机访谈之间的关系。
J Subst Abuse Treat. 2018 Apr;87:56-63. doi: 10.1016/j.jsat.2017.12.004. Epub 2017 Dec 13.
7
Methadone maintenance patients' knowledge, attitudes, beliefs, and experiences concerning treatment for hepatitis C virus infection.美沙酮维持治疗患者对丙型肝炎病毒感染治疗的知识、态度、信念和经验。
Subst Use Misuse. 2010 Mar;45(4):496-514. doi: 10.3109/10826080903452538.
8
Does psychiatric comorbidity affect drug abuse treatment outcome? A prospective assessment of drug abuse, treatment tenure and infectious diseases in an Israeli methadone maintenance clinic.精神疾病共病是否会影响药物滥用治疗结果?对以色列一家美沙酮维持治疗诊所中药物滥用、治疗疗程和传染病的前瞻性评估。
Isr J Psychiatry Relat Sci. 2006;43(2):126-36.
9
Characterization of former heroin addict patients with Hepatitis C virus antibodies in a methadone maintenance treatment (MMT) clinic in israel.以色列一家美沙酮维持治疗(MMT)诊所中丙型肝炎病毒抗体呈阳性的 former heroin addict 患者的特征分析 。 注:“former heroin addict”直译为“曾经的海洛因成瘾者”,这里表述稍显生硬,可根据上下文灵活调整为更通顺的表达,比如“曾经吸食过海洛因的患者” ,但按照要求未做修改。
Subst Use Misuse. 2007;42(9):1477-84. doi: 10.1080/10826080701212550.
10
Integrated internist - addiction medicine - hepatology model for hepatitis C management for individuals on methadone maintenance.美沙酮维持治疗个体丙型肝炎管理的综合内科医生-成瘾医学-肝病学模式。
J Viral Hepat. 2012 Jan;19(1):47-54. doi: 10.1111/j.1365-2893.2010.01411.x. Epub 2010 Dec 3.

引用本文的文献

1
The role of barriers to care on the propensity for hepatitis C virus nonreferral among people living with HIV.阻碍因素对 HIV 感染者丙型肝炎病毒转诊倾向的影响。
AIDS. 2020 Sep 1;34(11):1681-1683. doi: 10.1097/QAD.0000000000002610.
2
"They didn't give up on me": a women's transitions clinic from the perspective of re-entering women.“他们没有放弃我”:重新进入社会的女性视角下的女性过渡诊所
Addict Sci Clin Pract. 2019 Apr 2;14(1):12. doi: 10.1186/s13722-019-0142-8.
3
Unmet core needs for self-determination in HIV-infected women of color in medical care.感染艾滋病毒的有色人种女性在医疗护理中未得到满足的自主核心需求。
AIDS Care. 2017 May;29(5):603-611. doi: 10.1080/09540121.2016.1243788. Epub 2016 Oct 13.
4
Structural barriers in the context of opiate substitution treatment in Germany--a survey among physicians in primary care.德国阿片类物质替代治疗中的结构性障碍 - 初级保健医生调查。
Subst Abuse Treat Prev Policy. 2013 Jul 22;8:26. doi: 10.1186/1747-597X-8-26.
5
Increasing Hepatitis C treatment uptake among HIV-infected patients using an HIV primary care model.利用艾滋病初级护理模式提高感染 HIV 的丙型肝炎患者的治疗参与率。
AIDS Res Ther. 2013 Mar 28;10(1):9. doi: 10.1186/1742-6405-10-9.

本文引用的文献

1
A model for treating HCV hepatitis in patients receiving methadone maintenance therapy.一种针对接受美沙酮维持治疗患者的丙型肝炎治疗模型。
Isr J Psychiatry Relat Sci. 2014;51(4):303-5.
2
The working alliance: Where are we and where should we go?工作联盟:我们在哪里,我们应该去哪里?
Psychotherapy (Chic). 2006 Fall;43(3):271-9. doi: 10.1037/0033-3204.43.3.271.
3
Barriers to accessing care in patients with chronic hepatitis C: the impact of depression.慢性丙型肝炎患者获得治疗的障碍:抑郁的影响。
Aliment Pharmacol Ther. 2010 Nov;32(9):1163-73. doi: 10.1111/j.1365-2036.2010.04460.x. Epub 2010 Sep 17.
4
A transitional opioid program to engage hospitalized drug users.一项针对住院吸毒者的过渡性阿片类药物项目。
J Gen Intern Med. 2010 Aug;25(8):803-8. doi: 10.1007/s11606-010-1311-3. Epub 2010 Mar 17.
5
Knowledge about Hepatitis-C among methadone maintenance treatment patients in Israel.以色列美沙酮维持治疗患者对丙型肝炎的认知。
Subst Use Misuse. 2010;45(1-2):58-76. doi: 10.3109/10826080902864894.
6
The global burden of hepatitis C.丙型肝炎的全球负担。
Liver Int. 2009 Jan;29 Suppl 1:74-81. doi: 10.1111/j.1478-3231.2008.01934.x.
7
Hepatitis B and hepatitis C in 2009.2009年的乙型肝炎和丙型肝炎。
Liver Int. 2009 Jan;29 Suppl 1:1-8. doi: 10.1111/j.1478-3231.2008.01947.x.
8
Medication adherence: a review of the literature and implications for clinical practice.药物依从性:文献综述及对临床实践的启示
J Psychiatr Pract. 2009 Jan;15(1):34-44. doi: 10.1097/01.pra.0000344917.43780.77.
9
Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5-year follow-up of 150 patients.丙型肝炎病毒(HCV)治疗成功后的临床、病毒学、组织学和生化结果:150例患者的5年随访
Hepatology. 2009 Mar;49(3):729-38. doi: 10.1002/hep.22694.
10
Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.以色列非法药物使用者中的丙型肝炎、乙型肝炎和人类免疫缺陷病毒感染:患病率及风险因素。
Isr Med Assoc J. 2008 Nov;10(11):775-8.

以色列美沙酮治疗中心个体丙型肝炎病毒治疗动机增强方法的试点培训计划。

A pilot training program for a motivational enhancement approach to hepatitis C virus treatment among individuals in Israeli methadone treatment centers.

机构信息

Department of Psychiatry, University of Rochester Medical Center, Rochester, New York 14642, USA. diane

出版信息

Subst Use Misuse. 2012 Jan;47(1):56-66. doi: 10.3109/10826084.2011.628735.

DOI:10.3109/10826084.2011.628735
PMID:22216992
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3305804/
Abstract

Although hepatitis C virus (HCV) can be cleared, very few infected persons complete the treatment, resulting in disease progression and transmission. Motivational interventions effectively address health and substance-use-related conditions in many cultures. The research team piloted an HCV treatment motivational enhancement training and supervision for four counselors treating four patients in one (of 11) large methadone programs in Israel between 2007 and 2008. The counselors received a 3-day training followed by seven supervision sessions. Training included cultural and language adaptation from the original United States version to practice in Israel. Feasibility was assessed and demonstrated through training field notes and questionnaire feedback, review of taped intervention sessions for counselor proficiency and patient engagement, and patient completion of intervention sessions and piloted measures. While positive feasibility outcomes were noted, future studies should employ larger numbers of counselors and patients to assess the effectiveness of motivational enhancement in promoting HCV treatment in methadone patients.

摘要

虽然丙型肝炎病毒 (HCV) 可以被清除,但很少有感染者能完成治疗,导致疾病进展和传播。动机干预在许多文化中都能有效地解决健康和药物使用相关的问题。研究小组于 2007 年至 2008 年间在以色列的 11 个大型美沙酮项目中的一个项目中,对 4 名治疗 4 名患者的辅导员进行了 HCV 治疗动机增强培训和监督。辅导员接受了为期 3 天的培训,然后进行了 7 次监督会议。培训包括对原始美国版本进行文化和语言改编,以适应以色列的实践。通过培训现场记录和问卷调查反馈、评估辅导技能和患者参与度的录音干预会议回顾,以及患者完成干预会议和试点措施,评估并展示了可行性。虽然注意到了积极的可行性结果,但未来的研究应招募更多的辅导员和患者,以评估动机增强在促进美沙酮患者 HCV 治疗方面的效果。